key: cord-0697875-5akvrrt4
authors: Hurst, Jillian H.; Zhao, Congwen; Fitzpatrick, Nicholas S.; Goldstein, Benjamin A.; Lang, Jason E.
title: Reduced pediatric urgent asthma utilization and exacerbations during the COVID‐19 pandemic
date: 2021-07-21
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25578
sha: 697b0e0c9577ff9bdaab82633cac2239f9d215e2
doc_id: 697875
cord_uid: 5akvrrt4

The COVID‐19 pandemic has had a profound impact on healthcare access and utilization, which could have important implications for children with chronic diseases, including asthma. We sought to evaluate changes in healthcare utilization and outcomes in children with asthma during the COVID‐19 pandemic. We used electronic health records data to evaluate healthcare use and asthma outcomes in 3959 children and adolescents, 5–17 years of age, with a prior diagnosis of asthma who had a history of well‐child visits and encounters within the healthcare system. We assessed all‐cause healthcare encounters and asthma exacerbations in the 12‐months preceding the start of the COVID‐19 pandemic (March 1, 2019–February 29, 2020) and the first 12 months of the pandemic (March 1, 2020–February 28, 2021). All‐cause healthcare encounters decreased significantly during the pandemic compared to the preceding year, including well‐child visits (48.1% during the pandemic vs. 66.6% in the prior year; p < .01), emergency department visits (9.7% vs. 21.0%; p < .01), and inpatient admissions (1.6% vs. 2.5%; p < .01), though there was over a 100‐fold increase in telehealth encounters. Asthma exacerbations that required treatment with systemic steroids also decreased (127 vs. 504 exacerbations; p < .01). Race/ethnicity was not associated with changes in healthcare utilization or asthma outcomes. The COVID‐19 pandemic corresponded to dramatic shifts in healthcare utilization, including increased telehealth use and improved outcomes among children with asthma. Social distancing measures may have also reduced asthma trigger exposure.

before scheduled hospital admissions. 2, 3 Patients and families have also changed the way they interact with the healthcare system, with documented increases in missed appointments and routine health maintenance such as vaccinations, and avoidance of emergency rooms and urgent care centers. [4] [5] [6] [7] Such changes could have important implications for the health and well-being of children with chronic diseases who require regular touchpoints with the health system for disease management. Further, because comorbidities appear to increase the susceptibility to and severity of SARS-CoV-2 infections in adults, there are concerns that chronic medical conditions in children may also increase the risk of COVID- 19. 8 Asthma is the most common chronic condition among children less than 18 years of age, with more than 5.5 million children and adolescents in the United States estimated to have an asthma diagnosis. 9 Childhood asthma is primarily managed through regular assessment and monitoring, control of factors that aggravate symptoms, pharmacologic therapy, and education in symptom management and treatment. 10 Notably, all components require regular interactions with the health system to ensure timely evaluation and provision of prescriptions for controller and rescue medications. We and others have previously reported that children who have yearly well-child visits have decreased risk of asthma exacerbations and related emergency department visits compared with children who do not have regular well-child visits. 11 Similarly, continuity of care is associated with improved asthma outcomes in children and adolescents. [12] [13] [14] [15] [16] Taken together, these findings suggest that disruptions to healthcare access and utilization patterns may result in increased exacerbations and poor outcomes in children with asthma.

Because the COVID-19 pandemic has significantly altered healthcare provision and access, we hypothesized that the pandemic would markedly alter care patterns and health outcomes in children and adolescents with asthma. Further, stay-at-home orders, school closures, and other social distancing measures could alter exposures to common asthma triggers, including allergens and respiratory viruses. We previously characterized a cohort of over 5000 children and adolescents with asthma who receive primary care through an academic medical center-based healthcare system. Herein, we conducted pre-post cohort study using electronic health records (EHRs) data to evaluate healthcare utilization and asthma outcomes in children and adolescents in the 12 months before the beginning of the COVID-19 pandemic (March 1, 2019-February 29, 2020) and

the first year of the pandemic (March 1, 2020-February 28, 2021).

This study was evaluated by the Duke University Health System (DUHS) Institutional Review Board (Pro00091342). The requirement for informed consent was waived under 45 CFR 46.116. The DUHS is a comprehensive medical system that includes a large tertiary care hospital, which includes a children's health center and hospital, two community hospitals, and a network of primary and urgent care pediatric and family medicine clinics and inpatient and outpatient specialty services. DUHS is the primary care provider within Durham County, North Carolina, and is estimated to provide healthcare services, including primary and specialty care, for over 85% of Durham residents. We abstracted patient records from the DUHS EHR system to conduct a retrospective cohort study to assess changes in healthcare use and asthma outcomes in children and adolescents with asthma who receive primary care through the DUHS.

Patients included in the cohort were required to meet the following diagnoses, which we used to select patients for this study. 17 To meet the criteria for study-defined asthma, patients had to have (1) either an asthma-appropriate International Classification of Diseases, 10th

Revision (ICD-10) (J45.x) diagnosis code documented in the EHR problem list section or 2 or more outpatient or ED encounters (or 1 hospital encounter) with the appropriate ICD-10 coding and (2) documented prescription of 1 or more asthma medications.

We abstracted information on patient age, race, and ethnicity (categorized as non-Hispanic white, non-Hispanic black, Hispanic, and other), primary payor (based on most recent encounter to the March 1, 2020-the study midpoint), number and types of healthcare encounters within the DUHS, asthma exacerbations that required medical attention, SARS-CoV-2 testing and results, and antibiotic prescriptions.

We evaluated changes in healthcare utilization and asthma outcomes in the year before the COVID-19 pandemic ("Year 1": March 1, 2019-February 29, 2020) and the first year of the COVID-19 pandemic ("Year 2": March 1, 2020-February 28, 2021). The first outcomes of interest were the number and types of all-cause healthcare visits before and during the COVID-19 pandemic, including: wellchild visits, defined as scheduled primary care office-based encounters or initial consults that also had a diagnosis code representing routine health supervision ("z00.110," "z00.111," "z00.121," or "z00.129"); hospital encounters greater than 24 h in duration; hospital or emergency department encounters less than 24 h in duration; and all other outpatient encounters, including urgent care visits, telehealth encounters, and other encounters that do not meet criteria for the three prior categories. Additionally, we evaluated asthma-related healthcare utilization and the occurrence of asthma exacerbations, which were defined as encounter type with an asthma diagnosis code (J45.x) and the administration or prescription for an oral corticosteroid. Because upper respiratory infections, including SARS-CoV-2, could potentially contribute to asthma exacerbations, we assessed antibiotic prescriptions, the number of SARS-CoV-2 PCR tests, and the number of positive SARS-CoV-2 tests within our population. We also assessed potential impacts of stay-at-home and social distancing measures with respect to asthma exacerbation rates during the first year of the COVID-19 pandemic; state-wide social distancing and stay-at-home orders described in Table S1 . Lastly, to evaluate potential access disparities during the COVID-19 pandemic, we assessed healthcare encounters by race/ethnicity for encounters before and after the start of the pandemic.

The primary objective of the study was to assess the impact of the COVID-19 pandemic on healthcare utilization and asthma-related healthcare encounters and outcomes among children with asthma. We first described baseline patient characteristics. For our primary analysis, we assessed the type and number of healthcare encounters during the pre-pandemic year and the first year of the COVID-19 pandemic, reporting the number of encounters, percent of patients with a particular encounter type reported, and the median and interquartile range (IQR) for the number of visits for a given encounter type. We used a paired Wilcoxon test to assess differences in healthcare utilization in the pre-pandemic year compared to the first year of the COVID-19 pandemic. The same approaches were used to evaluate differences in asthma-associated healthcare encounters and asthma exacerbations. Data management and analyses were performed with R version 3.6.1.

We previously identified 5656 children 5 to <18 years of age who met the criteria for asthma diagnosis, had a Durham County address of residence, and were identified as receiving primary care through the DUHS. 11 Of this initial cohort, 3959 had at least one in-person healthcare encounter in the year before the start of the COVID-19 pandemic (Year 1) and were therefore included in the primary analysis. The demographic characteristics of this cohort are shown in Table 1 . (Table 3) .

Asthma exacerbations in children exhibit seasonal peaks that coincide with fall return to school and winter respiratory infections. [18] [19] [20] To assess whether these seasonal patterns continued Table S1 ).

We also evaluated markers of respiratory infections within the cohort, including antibiotic prescriptions and SARS-CoV-2 tests.

There was a significant decline in the number of antibiotic pre- None of the children with asthma within this cohort were hospitalized due to COVID-19.

We did not find any significant differences in healthcare use or in the number of asthma exacerbations based on race/ethnicity ( Figure S1 ).

We evaluated changes in healthcare utilization for children and adolescents with asthma before and after the start of the COVID-19 pandemic.

We found that overall healthcare utilization decreased in all settings, except for telehealth encounters, which increased dramatically during the COVID-19 pandemic. Importantly, asthma outcomes for the children and The reasons underlying improved asthma control and decreased acute care encounters for pediatric asthma are likely multifactorial. The

PeARL study reported decreased incidence of upper and lower respiratory infections and febrile episodes among children with and without asthma, suggesting that decreased infectious triggers could play a role in improved asthma outcomes. 24 Supporting the potential role of decreased respiratory infections, a single center study of children with asthma reported the absence of the typical fall seasonal spike in asthma exacerbations that has been attributed to increased circulation of common respiratory viruses associated with schools reopening, as well as increased exposure to indoor allergens, changes in outdoor allergens, and colder weather. 25 While we did not have access to data on incidence of respiratory infections, we did find a decrease in prescriptions for antibiotics commonly prescribed for respiratory infections, suggesting decreased infections in our study population. Moreover, we observed a marked decrease in the percentage of ambulatory encounters associated with antibiotic prescriptions, though the total number of ambulatory encounters (both outpatient and telehealth) increased, suggesting that there may have been fewer encounters due to suspected respiratory infections during the pandemic. There have been multiple epidemiological studies in multiple countries demonstrating decreases in rates of rhinoviruses, influenza, and respiratory syncytial virus that have been attributed to masking and social distancing measures. 26, 27 We also observed slight increases in asthma exacerbation rates that coincided with the timing of reopening orders, suggesting that reduced social distancing could have potentially been a contributing factor.

Our data demonstrate that telehealth visits increased significantly for children with asthma during the COVID-19 pandemic.

Though telehealth visits was available before the pandemic, only 15% of pediatricians reported using this visit modality before the pandemic. 28 An analysis of EHR data from 45 pediatric primary care practices showed rapid uptake of telehealth within the first month of initiation of stay-at-home orders, and continued use through May 2020, with the majority of visits pertaining to mental health and dermatological concerns. 29 Telehealth visits were inversely correlated with the number of in-person office visits, and the number of total encounters remained closer to pre-pandemic levels in practices using telehealth. A more recent study demonstrated associations between telehealth visit use and stay-at-home orders and phased reopening stages in pediatric practices. 30 In addition to telehealth, remote lung function evaluation, including home spirometry, has become more common during the COVID-19 pandemic; however, due to device and cost availability, this practice is not yet widespread. 31,32

Our study had several strengths. Our cohort included nearly 4000 children and adolescents who were established patients with the DUHS before the start of the COVID-19 pandemic, allowing assessment of changes in healthcare use and outcomes within a wellcharacterized population. We performed our analyses in a setting in which the patients receive the majority of their care within a single system, increasing confidence that all healthcare interactions have been captured for the population. Additionally, the population under study is highly diverse, providing an opportunity to evaluate potential inequities in healthcare and asthma outcomes. Despite these strengths, our study had several limitations. This is a single center study, so all findings may not be generalizable. We used an asthma exacerbation definition that required the prescription or administration of systemic steroids and therefore did not capture mild exacerbations. Further, we did not have access to asthma control or lung function data and cannot make any conclusions about overall asthma control, and we did not evaluate unstructured data, including clinical notes, that would provide additional context for our findings.

Finally, we used the prescription of antibiotics commonly used for respiratory infections as a surrogate for respiratory infection rates within the population, but do not have a more direct measure of respiratory infections or other potential exposures that could contribute to asthma outcomes within this population.

We conducted an analysis of healthcare utilization and asthma outcomes in children before and during the COVID-19 pandemic. We found that all encounter types decreased during the first year of the pandemic, with a compensatory increase in telehealth visits. Importantly, we observed a significant decrease in asthma exacerbations and associated healthcare encounters, suggesting that conditions during the pandemic contributed to improved asthma outcomes in children. Moreover, improvements were seen across the full population, regardless of race/ethnicity, indicating that there were no disparities in telehealth healthcare access or asthma outcomes. Future work should seek to fully evaluate the specific factors that contributed to improved outcomes in children with asthma, particularly with respect to factors that could be leveraged after the end of the COVID-19 pandemic, including the use of telehealth for the provision of care.

review & editing (equal). Benjamin A. Goldstein: conceptualization (equal); methodology (equal); resources (equal); supervision (equal);

writing review & editing (equal). Jason E Lang: conceptualization (equal); funding acquisition (equal); investigation (equal); supervision (equal); writing review & editing (equal).

The analytic data sets will be made available upon request to the authors.

Jillian H. Hurst http://orcid.org/0000-0001-5079-9920

Jason E. Lang https://orcid.org/0000-0001-9115-5312

The Impact of the COVID-19 Pandemic on Access to Health Care

Infection control practices in children during COVID-19 pandemic: Differences from adults

Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic

Delay or avoidance of medical care because of COVID-19-related concerns-United States

Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration-United States

COVID-19 related reduction in pediatric emergency healthcare utilization-a concerning trend

Service use among Medicaid & CHIP beneficiaries age 18 and under during COVID-19

Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States

Management of severe asthma in children

Well-child care attendance and risk of asthma exacerbations

Pediatric asthma hospitalizations among urban minority children and the continuity of primary care

A missed primary care appointment correlates with a subsequent emergency department visit among children with asthma

Relationship between pediatric primary provider visits and acute asthma ED visits

Association of lower continuity of care with greater risk of emergency department use and hospitalization in children

Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma

Performance of a computable phenotype for pediatric asthma using the problem list

Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens

The association of environmental, meteorological, and pollen count variables with asthmarelated emergency department visits and hospitalizations in the Bronx

Seasonal cycle and relationship of seasonal rhino-and influenza virus epidemics with episodes of asthma exacerbation in different age groups

Trends in US Pediatric Hospital Admissions in 2020 compared with the decade before the COVID-19 pandemic

Evaluating the impact of COVID-19 on asthma morbidity: a comprehensive analysis of potential influencing factors

Changes in pediatric intensive care unit utilization and clinical trends during the coronavirus pandemic

Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multinational cohort

Pediatric asthma exacerbations during the COVID-19 pandemic: Absence of the typical fall seasonal spike in

The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections

COVID-19 public health measures and respiratory syncytial virus

Pediatrician attitudes toward and experiences with telehealth use: results from a national survey

Practice-level variation in telemedicine use in a pediatric primary care network during the COVID-19 pandemic: retrospective analysis and survey study

Changes in primary care visits in the 24 weeks after COVID-19 stay-at-home orders relative to the comparable time period in 2019 in metropolitan Chicago and Northern Illinois

Initiating home spirometry for children during the COVID-19 pandemic-a practical guide

Paediatric and adolescent asthma: a narrative review of telemedicine and emerging technologies for the post-COVID-19 era

Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic